Ribociclib: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption=' | <StructureSection load='' size='340' side='right' caption='Ribociclib' scene='10/1004490/Cv/2'> | ||
Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib inhibits the enzymes [[Cyclin Dependent Kinase-4|cyclin-dependent kinase 4]] (CDK4) and cyclin-dependent kinase 6 (CDK6).<ref name="a7">[https://www.hcp.novartis.com/products/kisqali/metastatic-breast-cancer/ "Kisqali (ribociclib) Treatment: HR+/HER2- mBC". Novartis. Retrieved 24 August 2021.]</ref> See also [https://en.wikipedia.org/wiki/Ribociclib Ribociclib] and [[CDK4]]. | Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib inhibits the enzymes [[Cyclin Dependent Kinase-4|cyclin-dependent kinase 4]] (CDK4) and cyclin-dependent kinase 6 (CDK6).<ref name="a7">[https://www.hcp.novartis.com/products/kisqali/metastatic-breast-cancer/ "Kisqali (ribociclib) Treatment: HR+/HER2- mBC". Novartis. Retrieved 24 August 2021.]</ref> See also [https://en.wikipedia.org/wiki/Ribociclib Ribociclib] and [[CDK4]]. | ||
| Line 7: | Line 7: | ||
<scene name='10/1004490/Cv/3'>The X-ray co-crystal structure of human CDK6 and Ribociclib</scene> ([[5l2t]]). | <scene name='10/1004490/Cv/3'>The X-ray co-crystal structure of human CDK6 and Ribociclib</scene> ([[5l2t]]). | ||
<scene name='10/1004490/Binding_site/1'>Ribociclib binding ite</scene>. | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
